These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 28595491

  • 1. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.
    Song J, Sjölander A, Joas E, Bergen SE, Runeson B, Larsson H, Landén M, Lichtenstein P.
    Am J Psychiatry; 2017 Aug 01; 174(8):795-802. PubMed ID: 28595491
    [Abstract] [Full Text] [Related]

  • 2. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
    Hayes JF, Pitman A, Marston L, Walters K, Geddes JR, King M, Osborn DP.
    JAMA Psychiatry; 2016 Jun 01; 73(6):630-7. PubMed ID: 27167638
    [Abstract] [Full Text] [Related]

  • 3. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
    Yerevanian BI, Koek RJ, Mintz J.
    J Affect Disord; 2003 Feb 01; 73(3):223-8. PubMed ID: 12547290
    [Abstract] [Full Text] [Related]

  • 4. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
    Collins JC, McFarland BH.
    J Affect Disord; 2008 Apr 01; 107(1-3):23-8. PubMed ID: 17707087
    [Abstract] [Full Text] [Related]

  • 5. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
    Yerevanian BI, Koek RJ, Mintz J.
    J Affect Disord; 2007 Nov 01; 103(1-3):5-11. PubMed ID: 17628692
    [Abstract] [Full Text] [Related]

  • 6. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.
    Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, Burke AK, Harkavy-Friedman J, Sublette ME, Parsey RV, Mann JJ.
    Am J Psychiatry; 2011 Oct 01; 168(10):1050-6. PubMed ID: 21768611
    [Abstract] [Full Text] [Related]

  • 7. Suicide risk in bipolar disorder during treatment with lithium and divalproex.
    Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D.
    JAMA; 2003 Sep 17; 290(11):1467-73. PubMed ID: 13129986
    [Abstract] [Full Text] [Related]

  • 8. Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study.
    Smith EG, Austin KL, Kim HM, Miller DR, Eisen SV, Christiansen CL, Kilbourne AM, Sauer BC, McCarthy JF, Valenstein M.
    BMC Psychiatry; 2014 Dec 17; 14():357. PubMed ID: 25515091
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of the risk of suicidal behavior in bipolar-spectrum disorders.
    Cavazzoni P, Grof P, Duffy A, Grof E, Müller-Oerlinghausen B, Berghöfer A, Ahrens B, Zvolsky P, Robertson C, Davis A, Hajek T, Alda M.
    Bipolar Disord; 2007 Jun 17; 9(4):377-85. PubMed ID: 17547584
    [Abstract] [Full Text] [Related]

  • 10. Suicide death over the first year of lithium versus valproate treatment in cohorts with and without bipolar disorder.
    Smith EG, Austin KL, Kim HM, Miller DR, Sauer BC, Valenstein M.
    J Psychiatr Res; 2022 Mar 17; 147():349-356. PubMed ID: 35158303
    [Abstract] [Full Text] [Related]

  • 11. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
    Tsai CJ, Cheng C, Chou PH, Lin CH, McInnis MG, Chang CL, Lan TH.
    J Affect Disord; 2016 May 15; 196():71-7. PubMed ID: 26919054
    [Abstract] [Full Text] [Related]

  • 12. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.
    Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK.
    Br J Psychiatry; 2011 Jul 15; 199(1):57-63. PubMed ID: 21593515
    [Abstract] [Full Text] [Related]

  • 13. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.
    Cochrane Database Syst Rev; 2013 Oct 17; 2013(10):CD003196. PubMed ID: 24132760
    [Abstract] [Full Text] [Related]

  • 14. Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder.
    Köhler-Forsberg O, Rohde C, Nierenberg AA, Østergaard SD.
    JAMA Psychiatry; 2022 May 01; 79(5):454-463. PubMed ID: 35353126
    [Abstract] [Full Text] [Related]

  • 15. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study.
    Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP.
    PLoS Med; 2016 Aug 01; 13(8):e1002058. PubMed ID: 27483368
    [Abstract] [Full Text] [Related]

  • 16. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 17. Newer prophylactic agents for bipolar disorder and their influence on suicidality.
    Born C, Dittmann S, Post RM, Grunze H.
    Arch Suicide Res; 2005 Jun 01; 9(3):301-6. PubMed ID: 16020172
    [Abstract] [Full Text] [Related]

  • 18. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
    BALANCE investigators and collaboratorsOxford Clinical Trials Unit for Mental Illness, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK. john.geddes@psych.ox.ac.uk, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E.
    Lancet; 2010 Jan 30; 375(9712):385-95. PubMed ID: 20092882
    [Abstract] [Full Text] [Related]

  • 19. Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study.
    Leon AC, Solomon DA, Li C, Fiedorowicz JG, Coryell WH, Endicott J, Keller MB.
    Am J Psychiatry; 2012 Mar 30; 169(3):285-91. PubMed ID: 22193537
    [Abstract] [Full Text] [Related]

  • 20. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J.
    J Affect Disord; 2017 Aug 01; 217():16-23. PubMed ID: 28364619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.